Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase NA × Refractory Solid Tumors × pazopanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Carcinoma, Renal Cell 4 Sarcoma 2 Refractory Solid Tumors 2 Neoplasms 2 Kidney Neoplasms 1

Interventions

pazopanib 2 Sorafenib 2 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02450136 2022-06-15

Single-arm Study to Evaluate the Safety and Efficacy of Pazopanib, in Subjects With FGFR2 Amplification, FGFR2 Mutation Refractory Solid Tumors

Samsung Medical Center

Phase NA Completed

Other solid neoplasm

Refractory Solid Tumors

NCT02691767 2022-06-15

Study to Evaluate the Safety and Efficacy of Pazopanib, in Subject With Refractory Solid Tumors

Samsung Medical Center

Phase NA Completed

Other solid neoplasm

Refractory Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡